NOTE: This list is for informational purposes only and is not intended to have legal effect. Furthermore, this list does not include patents which have been extended only under § 156(e)(2) or § 156(d)(5) (patents which have only received an interim extension). Each patent number is hyperlinked to a copy of its certificate of extension, if available. A copy of the certificate of extension should be included in the "correction" section of the patent's images. See http://www.uspto.gov/patft/index.html to access the patent image database.

For further information, contact Mary C. Till, at (571) 272-7755 (telephone) or by e-mail at: mary.till@uspto.gov.

Please note that many patent term extension applications are available on PUBLIC PAIR; see http://portal.uspto.gov/external/portal/pair.

Additional information concerning patent expiration dates of human drug products can be obtained from the Food and Drug Administration, Center for Drug Evaluation and Research. The Patent and Exclusivity Addendum of the "Orange Book" the Approved Drug Products with Therapeutic Equivalents Evaluations includes an alphabetical listing of human drug products according to generic name with related patent information. The "Electronic Orange Book," a searchable version of the Orange Book, is available at: http://www.fda.gov/cder/ob/default.htm.

Some content linked to on this page requires a plugin for Acrobat Reader.

REQUIP

4,585,597

1 year
See Note 3

02-Jun-14